Principles and Practice of Pharmaceutical Medicine – Third Edition (PDF)

Principles and Practice of Pharmaceutical Medicine, Third Edition is a comprehensive and authoritative reference covering every major discipline within pharmaceutical medicine. This essential eBook provides in-depth insights into drug development, regulation, clinical research, pharmacovigilance, biotechnology, and global regulatory frameworks.

This updated edition includes expanded coverage on regulatory updates, international harmonization, translational and probabilistic approaches to drug development, personalized medicine, and the growing importance of pharmacovigilance and biotechnology.

📘 Key Features

• Comprehensive reference for pharmaceutical medicine professionals
• Coverage of clinical research, regulation, ethics, and global drug development
• Updated content reflecting modern regulatory and scientific advances
• Authored by leading international experts
• Ideal for physicians, researchers, regulatory professionals, and students

📖 Table of Contents

Foundations of Pharmaceutical Medicine

• Chapter 1: The Practice and Practitioners of Pharmaceutical Medicine – Anthony W. Fox
• Chapter 2: Pharmaceutical Medicine as a Medical Specialty – Michael D. Young & Peter D. Stonier
• Chapter 3: Clinical Research Education and Training – Peter Marks & Sheila Gwizdak
• Chapter 4: Drug Discovery: Design and Development – Ronald R. Cobb & Leslie J. Molony
• Chapter 5: Translational Medicine – Robert Sands & Douglas Roy

Clinical Development & Safety

• Chapter 6: Pharmaceutics – Anthony W. Fox
• Chapter 7: Nonclinical Toxicology – Frederick Reno
• Chapter 8: Informed Consent – Anthony W. Fox
• Chapter 9: Phase I Clinical Studies – Stephen H. Curry et al.
• Chapter 10: Phase II and III Clinical Studies – Anthony W. Fox
• Chapter 11: Phase IV Post-Marketing Studies – Lisa R. Johnson-Pratt
• Chapter 12: Site Management – Barry Miskin
• Chapter 13: Good Clinical Practices – Lionel D. Edwards
• Chapter 14: Quality Assurance and Audit – Rita Hattemer-Apostel

Special Populations & Therapeutic Areas

• Chapter 15: Over-the-Counter Medicine – Paul W. Starkey
• Chapter 16: Drug Research in Older Patients – Lionel D. Edwards
• Chapter 17: Drug Development in Women – Lionel D. Edwards
• Chapter 18: Clinical Research in Children – Lionel D. Edwards
• Chapter 19: Racial and Ethnic Issues in Drug Regulation – Multiple Authors
• Chapter 20: Hepatic and Renal Failure – Anthony W. Fox
• Chapter 21: Drug Interactions – Anthony W. Fox & Anne-Ruth van Troostenburg

Advanced Topics & Biotechnology

• Chapter 22: Orphan Drugs – Bert Spilker
• Chapter 23: QT Interval Prolongation – Bruce H. Morimoto & Anthony W. Fox
• Chapter 24: Biotechnology Products – David A. Shapiro & Anthony W. Fox
• Chapter 25: Health Economics – Daniel C. Malone et al.
• Chapter 26: Pharmacoeconomics – Raymond J. Townsend et al.
• Chapter 27: Pharmacoepidemiology – Hugh H. Tilson
• Chapter 28: Statistical Principles – Dan Anbar
• Chapter 29: Data Management – T. Y. Lee et al.
• Chapter 30: Patient Compliance – Jean-Michel Metry

Global Regulation & Policy

• Chapter 31: Drug Concentration Monitoring – Anthony W. Fox
• Chapter 32: Generics – Gabriel Lopez & Thomas Hoxie
• Chapter 33: Complementary Medicines – Anthony W. Fox
• Chapter 34: United States Regulations – William Kennedy & Lionel D. Edwards
• Chapter 35: Special US Regulatory Procedures – Anthony W. Fox
• Chapter 36: European Medicines Regulation – John P. Griffin
• Chapter 37: EU Medicines Regulation – Anne-Ruth van Troostenburg & Giuliana Tabusso
• Chapter 38: Japanese Regulations – Etienne Labbe
• Chapter 39: Middle East Drug Registration – Edda Freidank-Mueschenborn & Anja Konig
• Chapter 40: China’s Pharmaceutical Market – Yan Yan Li Starkey
• Chapter 41: India’s Pharmaceutical Evolution – Darshan Kulkarni

Professional Practice & Ethics

• Chapter 42: Medical Affairs – Gregory P. Geba
• Chapter 43: Drug Labeling – Anthony W. Fox
• Chapter 44: Data Mining – Mirza I. Rahman & Robbert P. van Manen
• Chapter 45: Risk Management – Anthony W. Fox
• Chapter 46: Publishing Clinical Studies – Anthony W. Fox
• Chapter 47: Organizing Scientific Meetings – Zofia Dziewanowska & Linda Packard
• Chapter 48: Drug Withdrawals – Ronald D. Mann
• Chapter 49: International Clinical Trials – Katie P. J. Wood
• Chapter 50: Bioethics – Andrew J. Fletcher
• Chapter 51: Pharmaceutical Law – Sarah Croft
• Chapter 52: Fraud and Misconduct – Jane Barrett
• Chapter 53: Multinational Pharmaceutical Corporations – R. Drucker & R. Graham Hughes
• Chapter 54: Advertising and Marketing – Jonathan Belsey
• Chapter 55: Product Liability – Han W. Choi & Jae Hong Lee
• Chapter 56: Patents – Gabriel Lopez
• Chapter 57: Outsourcing to CROs – John R. Vogel
• Chapter 58: Managed Care and the US Pharmaceutical Industry – Robert J. Chaponis et al.

📥 Format

• Digital Format: PDF
• Instant Download
• High-quality searchable text

🎯 Ideal For

• Pharmaceutical physicians
• Clinical research professionals
• Regulatory affairs specialists
• Medical students and educators
• Biotechnology and pharmaceutical industry professionals

Enhance your professional knowledge with one of the most authoritative references in pharmaceutical medicine.